AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇲

Imatinib Mesylate in Zambia

1 product registered with ZAMRA 1 active

Brand / ProductReg. No.HolderStatusExpires
Imatib 100 Capsules
Capsules
099/241Cipla Ltdactive19 Mar 2030

Imatinib MesylateZAMRA Registration Details

ZAMRA (Zambia) has 1 registered product containing Imatinib Mesylate, of which 1 is currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.

Track Imatinib Mesylate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.